Morgan Dempsey Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Morgan Dempsey Capital Management's LLY Position: Q2 2026 in Review
Morgan Dempsey Capital Management reduced its Eli Lilly (LLY) stake by 79% in Q2 2026, selling an estimated $85.8K and leaving 23 shares worth $27.6K. The position accounts for 0.01% of the portfolio, ranked #87.
Morgan Dempsey Capital Management first reported a position in LLY in Q2 2013 and has held it in 25 quarters since. The position peaked at $1.19M in Q2 2015. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Morgan Dempsey Capital Management held 23 shares of Eli Lilly worth $27.6K as of Q2 2026.
- Morgan Dempsey Capital Management sold 84 Eli Lilly shares in Q2 2026, an estimated $85.8K.
- Eli Lilly made up 0.01% of Morgan Dempsey Capital Management's portfolio in Q2 2026, its #87 holding.
- Morgan Dempsey Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 25 quarters since.
- Morgan Dempsey Capital Management's Eli Lilly position peaked at $1.19M in Q2 2015.
- 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Morgan Dempsey Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.